As counterfeit drugs have hit the market, ICE has worked even more diligently to get these drugs out of the stream of commerce and make sure that individuals and organizations that manufacture and market counterfeit drugs are prosecuted.  In the last 18 months, investigations conducted by ICE Homeland Security Investigations (HSI), in concert with industry partners and the Food and Drug Administration (FDA), resulted in 22 criminal convictions for individuals involved in counterfeit pharmaceuticals.


One of ICE HSI's most significant cases involved Houston resident Kevin Xu. Xu's company sold counterfeit drugs online and distributed them throughout the United States and United Kingdom, primarily through the mail and courier services. Legitimate wholesalers began selling these counterfeit drugs, not realizing that the products weren't the real thing. Ultimately, this led to three recalls of nearly $9 million of medication in the United Kingdom. Xu was prosecuted in 2009, ordered to serve 78 months in prison and pay restitution of $1.28 million.